Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Peripheral Arterial Disease D058729 7 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Acute Lung Injury D055371 33 associated lipids
Lung Injury D055370 14 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Ileus D045823 3 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Endotoxemia D019446 27 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Teratocarcinoma D018243 7 associated lipids
Weight Gain D015430 101 associated lipids
Reperfusion Injury D015427 65 associated lipids
Vascular Diseases D014652 16 associated lipids
Tuberculosis D014376 20 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Sensation Disorders D012678 2 associated lipids
Sarcoma 180 D012510 21 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Retinal Detachment D012163 10 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pulmonary Edema D011654 23 associated lipids
Psoriasis D011565 47 associated lipids
Proteinuria D011507 30 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pain D010146 64 associated lipids
Ovarian Diseases D010049 5 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Neuroblastoma D009447 66 associated lipids
Neuralgia D009437 28 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Vasta V et al. Sphingosine 1-phosphate induces arachidonic acid mobilization in A549 human lung adenocarcinoma cells. 2000 Biochim. Biophys. Acta pmid:10601704
An S et al. Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. 2000 J. Biol. Chem. pmid:10617617
Pyne S and Pyne N Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. 2000 Pharmacol. Ther. pmid:11150592
Conway A et al. Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells. 2000 Cell. Signal. pmid:11152959
Edsall L et al. Enzymatic method for measurement of sphingosine 1-phosphate. 2000 Meth. Enzymol. pmid:11070858
Sullards MC Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. 2000 Meth. Enzymol. pmid:11070861
Van Brocklyn JR and Spiegel S Binding of sphingosine 1-phosphate to cell surface receptors. 2000 Meth. Enzymol. pmid:11070888
Yatomi Y et al. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. 2000 Blood pmid:11071638
Fukushima N [A family of lysophospholipid receptors]. 2000 Seikagaku pmid:11076202
Kozawa O et al. Enhancement by sphingosine 1-phosphate in vasopressin-induced phosphoinositide hydrolysis in aortic smooth-muscle cells: involvement of p38 MAP kinase. 2000 J. Cell. Biochem. pmid:11029753
Kupperman E et al. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. 2000 Nature pmid:10910360
Mandala SM et al. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10859351
Murata N et al. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. 2000 Anal. Biochem. pmid:10860507
Siess W et al. Lysophosphatidic acid and sphingosine 1-phosphate: two lipid villains provoking cardiovascular diseases? 2000 IUBMB Life pmid:10868905
Caligan TB et al. A high-performance liquid chromatographic method to measure sphingosine 1-phosphate and related compounds from sphingosine kinase assays and other biological samples. 2000 Anal. Biochem. pmid:10847608
Igarashi J and Michel T Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. 2000 J. Biol. Chem. pmid:10921915
Racké K et al. Potential role of EDG receptors and lysophospholipids as their endogenous ligands in the respiratory tract. 2000 Pulm Pharmacol Ther pmid:10873548
Kim JH et al. Sphingosine 1-phosphate activates Erk-1/-2 by transactivating epidermal growth factor receptor in rat-2 cells. 2000 IUBMB Life pmid:11185956
Nanjundan M and Possmayer F Characterization of the pulmonary N-ethylmaleimide-insensitive phosphatidate phosphohydrolase. 2000 Jul-Aug Exp. Lung Res. pmid:10914334
Meyer zu Heringdorf D et al. Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors. 2001 Eur. J. Pharmacol. pmid:11239914
Young KW and Nahorski SR Intracellular sphingosine 1-phosphate production: a novel pathway for Ca2+ release. 2001 Semin. Cell Dev. Biol. pmid:11162743
English D et al. Platelet-released phospholipids link haemostasis and angiogenesis. 2001 Cardiovasc. Res. pmid:11166272
Radin NS Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? 2001 Eur. J. Biochem. pmid:11168352
Siehler S et al. Sphingosine 1-phosphate activates nuclear factor-kappa B through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells. 2001 J. Biol. Chem. pmid:11673450
Cuvillier O and Levade T Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. 2001 Blood pmid:11675357
Tigyi G Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family. 2001 Mol. Pharmacol. pmid:11723220
Castillo SS and Teegarden D Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells. 2001 J. Nutr. pmid:11694603
Lyons JM and Karin NJ A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells. 2001 J. Bone Miner. Res. pmid:11697799
Hornuss C et al. Human and rat alveolar macrophages express multiple EDG receptors. 2001 Eur. J. Pharmacol. pmid:11698050
Yoshida A and Ueda H Neurobiology of the Edg2 lysophosphatidic acid receptor. 2001 Jpn. J. Pharmacol. pmid:11700008
Im DS et al. Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors. 2001 Biochemistry pmid:11705398
Rosenfeldt HM et al. The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility. 2001 Biochem. Soc. Trans. pmid:11709084
Manggau M et al. 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. 2001 J. Invest. Dermatol. pmid:11710939
Tamama K et al. Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. 2001 Biochem. J. pmid:11115407
Sullards MC and Merrill AH Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. 2001 Sci. STKE pmid:11752637
Okajima F [Establishment of the method for the measurement of sphingosine-1-phosphate in biological samples and its application for S1P research]. 2001 Nippon Yakurigaku Zasshi pmid:11778456
Tosaka M et al. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. 2001 Stroke pmid:11739995
Ohanian J and Ohanian V Sphingolipids in mammalian cell signalling. 2001 Cell. Mol. Life Sci. pmid:11814056
Wang DA et al. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors. 2001 J. Biol. Chem. pmid:11604399
Andor A et al. YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. 2001 Cell. Microbiol. pmid:11298653
Ammit AJ et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. 2001 FASEB J. pmid:11344091
Yatomi Y et al. Sphingosine 1-phosphate: synthesis and release. 2001 Prostaglandins Other Lipid Mediat. pmid:11324700
Goetzl EJ Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids. 2001 Prostaglandins Other Lipid Mediat. pmid:11324701
Olivera A and Spiegel S Sphingosine kinase: a mediator of vital cellular functions. 2001 Prostaglandins Other Lipid Mediat. pmid:11324702
Hla T Sphingosine 1-phosphate receptors. 2001 Prostaglandins Other Lipid Mediat. pmid:11324703
Mandala SM Sphingosine-1-phosphate phosphatases. 2001 Prostaglandins Other Lipid Mediat. pmid:11324704
Lynch KR and Macdonald TL Structure activity relationships of lysophospholipid mediators. 2001 Prostaglandins Other Lipid Mediat. pmid:11324706
Panetti TS et al. Modulation of cell interactions with extracellular matrix by lysophosphatidic acid and sphingosine 1-phosphate. 2001 Prostaglandins Other Lipid Mediat. pmid:11324710
Alderton F et al. G-protein-coupled receptor stimulation of the p42/p44 mitogen-activated protein kinase pathway is attenuated by lipid phosphate phosphatases 1, 1a, and 2 in human embryonic kidney 293 cells. 2001 J. Biol. Chem. pmid:11278307
Takuwa Y et al. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. 2001 Mol. Cell. Endocrinol. pmid:11377814